Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients.

Herpes group viruses (herpes simplex virus, HSV; varicella-zoster virus, VZV; cytomegalovirus, CMV; and Epstein-Barr virus, EBV) remain an important cause of morbidity in immunocompromised persons. The aim of the study was to analyze the prevalence of HSV-1, HSV-2, VZV, CMV and EBV in patients undergoing hemodialysis. During a three-year period (2013-2015), 152 consecutive serum samples from hemodialysis patients and 150 healthy subjects (control group) were tested for the presence of IgM/IgG antibodies to herpes group viruses. Serologic tests were performed using a commercial enzyme-linked immunosorbent assay (ELISA) or enzyme-linked immunofluorescent assay (ELFA). Hemodialysis patients showed significantly higher CMV IgG seropositivity compared to controls (88.2% vs. 78.7%, p=0.011). In addition, seroprevalence rates of HSV-1 and VZV were higher in hemodialysis patients; however, these differences did not reach statistical significance (85.5% vs. 80.0%, p=0.054 and 99.3% vs. 96.0%, p=0.051, respectively). The prevalence of HSV-2 and EBV was similar in both groups (12.5% vs. 12.7%, p=0.137 and 98.0% vs. 95.3%, p=0.113, respectively). There was no difference in IgG seropositivity according to gender and place of residence. Logistic regression showed that older age was a significant predictor for CMV and EBV IgG seropositivity (increase in age by one year: CMV OR=1.055; 95%CI=1.030-1.080 and EBV OR=1.075, 95%CI=1.023-1.130).

[1]  D. Navarro.  Expanding role of cytomegalovirus as a human pathogen , 2016, Journal of medical virology.

[2]  B. Kolarić,et al.  Prevalence and dynamics of cytomegalovirus infection among patients undergoing chronic hemodialysis , 2015, Indian journal of nephrology.

[3]  M. Faramarzi,et al.  The role of Screening for Herpes Simplex Virus in Candidates of Renal Transplantation , 2015 .

[4]  I. Saadoon.  Frequency of CMV- Infection among Hemodialysis Patients in Tikrit City , 2015 .

[5]  H. Balfour,et al.  Infectious Mononucleosis. , 2015, Current topics in microbiology and immunology.

[6]  L. Abdulameer,et al.  Seroprevalence of human cytomegalovirus among hemodialysis patients in Diayala province , 2014 .

[7]  M. Talebi-Taher,et al.  Seroprevalence of antibodies against varicella-zoster virus among prevalent hemodialysis patients. , 2013, Iranian journal of kidney diseases.

[8]  J. Fishman.  Overview: Cytomegalovirus and the Herpesviruses in Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  M. Ardalan.  Rare Presentations of Cytomegalovirus Infection in Renal Allograft Recipients , 2012, Nephro-urology monthly.

[10]  P. Kes,et al.  Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome. , 2011, Acta clinica Croatica.

[11]  P. Kes,et al.  Varicella Zoster Infection in Renal Transplant Recipients: Prevalence, Complications and Outcome , 2011, Kidney and Blood Pressure Research.

[12]  K. Mazur-Melewska,et al.  Human cytomegalovirus infection as a lifelong health problem , 2011 .

[13]  V. Jha,et al.  Post-transplant infections: An ounce of prevention , 2010, Indian journal of nephrology.

[14]  M. Cannon,et al.  Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection , 2010, Reviews in medical virology.

[15]  A. Ghafari,et al.  Seroprevalence of herpes simplex virus-2 in kidney transplant recipients: a single-center experience. , 2010, Iranian journal of kidney diseases.

[16]  N. Sepehrvand,et al.  Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran. , 2008, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[17]  C. Pattaro,et al.  Viral hepatitis, HIV, human herpes virus and Treponema pallidum infection in haemodialysis patients from Kosovo, 2005. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  A. Heidari,et al.  Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran? , 2009, Transplantation proceedings.

[19]  R. Zietse,et al.  Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  W. Weimar,et al.  Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates. , 2006, Transplantation proceedings.

[21]  S. Ocak,et al.  Seroprevalence of Cytomegalovirus Antibodies in Haemodialysis Patients , 2006 .

[22]  W. Carman,et al.  Fulminating varicella despite prophylactic immune globulin and intravenous acyclovir in a renal transplant recipient: should renal patients be vaccinated against VZV before transplantation? , 2006, Clinical transplantation.

[23]  L. Gachkar,et al.  Prevalence of cytomegalovirus infection in hemodialysis patients in Labbafinejad Hospital in 2002-2003 , 2005 .

[24]  T. Albrecht,et al.  Human cytomegalovirus , 1990, Archives of Virology.

[25]  H. Doerr,et al.  [Cytomegalovirus diagnosis in blood donors and risk patients]. , 1990, Beitrage zur Infusionstherapie = Contributions to infusion therapy.